India  

Oxford–AstraZeneca COVID-19 vaccine

Vaccine against COVID-19

Oxford–AstraZeneca COVID-19 vaccine    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Oxford–AstraZeneca COVID-19 vaccine: Vaccine against COVID-19
The Oxford–AstraZeneca COVID-19 vaccine, codenamed AZD1222, and sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for prevention of COVID-19. Developed by Oxford University and AstraZeneca, it is given by intramuscular injection, using as a vector the modified chimpanzee adenovirus ChAdOx1. The efficacy of the vaccine is 76.0% at preventing symptomatic COVID-19 beginning at 22 days following the first dose and 81.3% after the second dose. Another analysis showed that, for symptomatic COVID-19 infection after the second dose, the vaccine is 66% effective against the Alpha variant, and 60% against the Delta variant.

0
shares
ShareTweetSavePostSend
 
Covishield dose gap: Dr Harsh Vardhan says decision based on scientific data | Oneindia News [Video]

Covishield dose gap: Dr Harsh Vardhan says decision based on scientific data | Oneindia News

Union Health Minister Dr Harsh Vardhan tweeted Wednesday that The decision to increase the gap between two doses of the Covishield vaccine was transparent and based on scientific data. He wrote, 'The..

Credit: Oneindia     Duration: 02:06Published
Covishield 2nd dose can be taken before 84 days if travelling abroad for these reasons|Oneindia News [Video]

Covishield 2nd dose can be taken before 84 days if travelling abroad for these reasons|Oneindia News

If you need to travel abroad for work or join a university, and are worried as the wait for the second dose of the vaccine is longer then don't worry as now accordingly to the urgency a person..

Credit: Oneindia     Duration: 02:01Published
AIIMS study: 'Delta' variant can infect people jabbed with Covishield or Covaxin | Oneindia News [Video]

AIIMS study: 'Delta' variant can infect people jabbed with Covishield or Covaxin | Oneindia News

According to separate studies by AIIMS and the National Centre for Disease Control, the 'delta' variant of COVID-19 is capable of infecting people even after they have received both doses of the..

Credit: Oneindia     Duration: 01:46Published
Vaccine prices at private hospitals capped by centre| Covidshield| Covaxin| Sputnik V| Oneindia News [Video]

Vaccine prices at private hospitals capped by centre| Covidshield| Covaxin| Sputnik V| Oneindia News

A day after Prime Minister Narendra Modi capped the service charge of vaccines administered by private hospitals at Rs 150, the Centre on Tuesday fixed the maximum price for Covid vaccines to be given..

Credit: Oneindia     Duration: 02:04Published
Prime Minister Narendra Modi to address the nation at 5 pm today| Covid-19| Oneindia News [Video]

Prime Minister Narendra Modi to address the nation at 5 pm today| Covid-19| Oneindia News

Covid-19, Coronavirus Pandemic, Covid-19 cases in India, 'Jahan vote, Wahan vaccination', Covidshield, Covaxin, Door to Door vaccination, Pakistan train collision, Pak PM Imran Khan, Ivermectin,..

Credit: Oneindia     Duration: 02:46Published
Lucknow man files complaint against Adar Poonawalla for 'no antibodies' despite jab | Oneindia News [Video]

Lucknow man files complaint against Adar Poonawalla for 'no antibodies' despite jab | Oneindia News

A man in Lucknow has filed a complaint against Serum Institute of India CEO Adar Poonawalla and others, alleging that he did not develop antibodies despite taking a Covishield dose. The complaint has..

Credit: Oneindia     Duration: 01:48Published
BJP Minister Prakash Javadekar says India will be fully vaccinated by December 2021 | Oneindia News [Video]

BJP Minister Prakash Javadekar says India will be fully vaccinated by December 2021 | Oneindia News

Union Minister, BJP, Ministry of Environment, Forest and Climate Change, Ministry of Information and Broadcasting, Ministry of Heavy Industries and Public Enterprises, Congress leader, Congress MP,..

Credit: Oneindia     Duration: 02:01Published
Vaccine goof up: UP villagers given vaccine cocktail, probe ordered | Oneindia News [Video]

Vaccine goof up: UP villagers given vaccine cocktail, probe ordered | Oneindia News

West Bengal Chief Minister Mamata Banerjee said that at least one crore people in the state were affected by rough weather conditions and high tide arising out of the cyclonic storm Yaas; The Centre..

Credit: Oneindia     Duration: 03:11Published
Dr Fauci said this on increasing gap between Covishield doses | Oneindia News [Video]

Dr Fauci said this on increasing gap between Covishield doses | Oneindia News

Imported coronavirus disease vaccine produced by Russia, Sputnik V, will cost ₹995.40 per dose in India and the price of vaccines produced in the country may be lower; White House chief medical..

Credit: Oneindia     Duration: 03:01Published
Vaccine for Covid recovered: Take after 6 months, says panel | Oneindia News [Video]

Vaccine for Covid recovered: Take after 6 months, says panel | Oneindia News

The Maharashtra government today extended the lockdown-like restrictions in the state to control the coronavirus outbreak till June 1. The gap between two doses of the Covishield vaccine can be..

Credit: Oneindia     Duration: 03:19Published
Delhi Govt sends SOS to Centre, 'Covaxin shots to last a day, Covidshield 3-4 days'| Oneindia News [Video]

Delhi Govt sends SOS to Centre, 'Covaxin shots to last a day, Covidshield 3-4 days'| Oneindia News

Delhi Govt says 'only enough Covaxin to last only a day and Covishield enough for around four days, in an SOS to the Centre. Sonia Gandhi on Monday demanded that the party take note of serious..

Credit: Oneindia     Duration: 02:41Published

Raipur gets 25 boxes of Covishield vaccine from Mumbai [Video]

Raipur gets 25 boxes of Covishield vaccine from Mumbai

A consignment of 25 boxes of Covishield vaccine arrived at Raipur from Mumbai. Following Chhattisgarh High Court orders, the stare government had commenced vaccination drive for citizens between 18-44..

Credit: ANI     Duration: 01:10Published
Chhattisgarh will receive 3.50 lakh doses of Covishield today [Video]

Chhattisgarh will receive 3.50 lakh doses of Covishield today

Health Minister of Chhattisgarh, TS Singh Deo on May 08 said the state government will receive 3.50 lakh doses of Covishield today and the further vaccination will go on with this. "We received 1.50..

Credit: ANI     Duration: 01:25Published
Vaccine production is truly international collaboration in India: EAM [Video]

Vaccine production is truly international collaboration in India: EAM

Union External Affairs Minister, Dr S Jaishankar attended a virtual conversation, called 'Global Dialogue Series' on May 05. He said, "Our vaccine production situation was different from many other..

Credit: ANI     Duration: 01:57Published
1 lakh inoculated so far in 18-44 age groups: Rajesh Tope [Video]

1 lakh inoculated so far in 18-44 age groups: Rajesh Tope

Speaking on COVID-19 situation in Maharashtra, State Health Minister Rajesh Tope on May 04 said, "Few centres were closed yesterday due to doses' shortage. Got 9 lakh vials today, to last for 2-3 days...

Credit: ANI     Duration: 01:40Published
Vaccine single dose: Is it efficient? Studies say this...| Oneindia News [Video]

Vaccine single dose: Is it efficient? Studies say this...| Oneindia News

While it must be understood that taking both doses of any vaccine whether it be Covishield, Covaxin or Sputnik, the ones that are available in India, are critical, here is what we know about one dose..

Credit: Oneindia     Duration: 01:30Published
‘Will return to India in a few days’: Adar Poonawalla after alleged threat calls [Video]

‘Will return to India in a few days’: Adar Poonawalla after alleged threat calls

Serum Institute of India CEO Adar Poonawalla, who has been in the UK on extended stay to evade alleged threats in India over ever-increasing demand for COVID-19 vaccines, has said he will return in a..

Credit: HT Digital Content     Duration: 01:50Published
‘Getting aggressive calls…’: Adar Poonawalla on Covid vaccine pressure in India [Video]

‘Getting aggressive calls…’: Adar Poonawalla on Covid vaccine pressure in India

Serum Institute of India CEO Adar Poonawalla on Saturday spoke out about the pressures he was under over the production of COVID-19 vaccines to meet the ever-increasing demand in India as the country..

Credit: HT Digital Content     Duration: 01:43Published
India receives first lot of Sputnik V vaccine [Video]

India receives first lot of Sputnik V vaccine

India on May 01 got the first lot of Russia's Sputnik V vaccine. The shipment arrived at the Hyderabad airport where Indian authorities received the first batch of 1.5 lakh doses of the Russia-made..

Credit: ANI     Duration: 02:00Published
Vaccination for 18 plus in Uttarakhand won't start on May 01: Health Secretary [Video]

Vaccination for 18 plus in Uttarakhand won't start on May 01: Health Secretary

Vaccination drive for 18-45 age groups will start after first week of May, informed Health Secretary of Uttarakhand, Amit Negi on April 30 during a press conference in Dehradun. "GoI has allotted..

Credit: ANI     Duration: 01:17Published

You Might Like


Covid-19: Decision to extend gap between doses was unanimous, says govt

The decision to increase the gap between two doses of Covishield vaccine from 4-6 weeks to 12-16 weeks was “unanimous” and based on studies that showed that a longer interval resulted in higher..
IndiaTimes - Published

No quarantine for Covishield vaccinated Indians in South Korea, mandatory for Covaxin recipients: Envoy


IndiaTimes - Published

'Decision based on scientific data': Govt defends move to increase gap between Covishield doses


IndiaTimes - Published

Covishield dose interval under discussion: NTAGI working group chairman

Discussions are underway whether India should revert to 4 or 8 weeks interval for the Covishield vaccine and the emerging evidence regarding the efficacy of partial versus full immunisation is also..
IndiaTimes - Published

Based on scientific evidence gap extended between two Covishield doses: Government panel

Arora's statements come amid reports claiming that the government doubled the gap of Covishield shots without the agreement of the scientific group.
DNA - Published

SII, Bharat Biotech seek hike in government price for Covid vaccines

Serum Institute of India (SII) and Bharat Biotech (BB) are seeking higher prices for Covid-19 vaccines from the Centre amid concerns that the cost of Covishield and Covaxin shots in private hospitals..
IndiaTimes - Published

One dose of vaccine enough for those who recovered from COVID-19: Study

The study was conducted on 260 health care workers who received a single dose of the Covishield vaccine between January 16 and February 5.
DNA - Published

'No need for immediate change': Centre on dosage interval of Covishield vaccine

Dr VK Paul, member (Health) at NITI Aayog, said that these decisions must be taken very carefully.
DNA - Published Also reported by •IndiaTimes

Delta variant can cause COVID-19 infections despite Covishield, Covaxin jabs, shows new study

The AIIMS study was conducted on 63 subjects who had breakthrough infections - 36 of whom had received two doses, while 27 had gotten one dose.
DNA - Published

Covid vaccine: Govt pre-orders 44 crore shots for Aug-Dec

A day after the government announced it was again centralising the Covid-19 vaccination programme, barring a 25% quota for domestic vaccine production for private hospitals, the health ministry placed..
IndiaTimes - Published

Centre caps vaccine prices; Covishield at Rs 780, Covaxin Rs 1,410


IndiaTimes - Published Also reported by •DNA

Govt places orders for 44 crore doses of Covishield & Covaxin

The Centre on Tuesday said it has placed orders for 44 crore doses of Covishield and Covaxin, a day after Prime Minister Narendra Modi announced that the Centre would take over the state procurement..
IndiaTimes - Published

Covishield vaccination schedule changed again, these people can get second dose after 28 days

At present, the second dose of the Covishield vaccine is administered at 12-16 weeks after the first dose.
DNA - Published

Covishield produces more antibodies than Covaxin, finds study

Covishield, from the Oxford-AstraZeneca stable, is manufactured by the Serum Institute of India in Pune. Covaxin is the indigenously manufactured vaccine by Hyderabad-based Bharat Biotech in..
IndiaTimes - Published

Seropositivity rate, anti-spike antibody higher in Covishield than Covaxin: Study

The study is titled, Antibody Response after Second-dose of ChAdOx1-nCOV (CovishieldTM) and BBV-152 (CovaxinTM) among Health Care Workers in India: Final Results of Cross-sectional Coronavirus..
IndiaTimes - Published

Good immune response from Covishield & Covaxin: Study

A ‘real-world’ study of vaccinated healthcare workers has found Covishield and Covaxin could produce a high immune response in up to 95% recipients and prevent serious disease in those infected..
IndiaTimes - Published

US to ease Covid vaccine input supply: Kamala Harris to PM Modi

US Vice-President Kamala Harris on Thursday spoke to PM Narendra Modi to brief him about the Biden administration’s new vaccine policy that will clear supply chains for AstraZeneca and Novavax..
IndiaTimes - Published

Pune airport handled domestic transportation of over 10 crore Covishield doses till May 27: AAI


IndiaTimes - Published

Covid-19: Frequently asked questions about Serum's Covishield vaccine


IndiaTimes - Published

SII unable to supply Covishield vaccine, Maldives looks elsewhere


IndiaTimes - Published

India to start trials on safety, efficacy of mixing vaccine doses

India will soon start trials to test the safety, immunogenicity and efficacy after mixing doses of different brands of Covid-19 vaccines. While the trials will currently include Covaxin, Covishield and..
IndiaTimes - Published

Will be able to manufacture, supply 10 crore Covishield doses in June: Serum Institute to Centre


IndiaTimes - Published

20 in UP village get Covishield, Covaxin cocktail


IndiaTimes - Published

ICMR to examine effectiveness of AstraZeneca's Covishield and Bharat Biotech's Covaxin


IndiaTimes - Published

‘India to stick to 12-16 week gap for Covishield doses’

The NTAGI has decided against any further changes in the dosing gap at the moment. Experts are of the view that the first dose generates adequate antibodies to protect from severe infection, whereas..
IndiaTimes - Published

Serum Institute of India, Bharat Biotech producing minimum 8 crore doses/month, yet only 5 crore will be given by May-end

The government in an affidavit in the Supreme Court earlier this month averred that Serum Institute of India (SII) was producing 6.5 crore doses of Covishield a month and Bharat Biotech was producing 2..
IndiaTimes - Published

India to begin Sputnik V production in August, says envoy Venkatesh Varma

Sputnik V, Covishield and Covaxin are the only three COVID vaccines allowed for use in India.
DNA - Published

‘Covaxin shots gap unchanged as protection after 1st dose not high’

Explaining the government decision to make a three month interval mandatory for Covishield, ICMR head Dr Balram Bhargava said the immunity post the first shot was found to be quite strong. He said a..
IndiaTimes - Published

SCBA writes to health ministry to sanction Covishield doses on urgent basis


IndiaTimes - Published

3-month gap between doses improves immune response: AZ vax co-developer

A three-month gap between two doses of the AstraZeneca vaccine, known in India as Covishield, improves the immune response against Covid-19, according to Andrew Pollard, co-developer of the vaccine and..
IndiaTimes - Published

Clot cases post-Covishield jab miniscule: Govt panel

Blood clots or thromboembolic events after vaccination with Covishield were reported in just 0.61 cases per million doses in India, while no such events were found following Covaxin jabs, the Adverse..
IndiaTimes - Published

Covishield 2nd dose appointments cancelled in some states

Though the Centre, in a letter to states and UTs, has advised them to allow people who booked appointments for a second dose of Covishield prior to the new schedule of 12-16 weeks to be given their..
IndiaTimes - Published

Bleeding, clotting events post COVID vaccination 'minuscule' in India: Govt panel

India has reported 26 potential cases of bleeding and clotting after the administration of Covishield vaccine.
DNA - Published

New Covishield schedule of 12-16 wks in CoWin

The government has reconfigured the CoWin platform to reflect the new dosing schedule of 12-16 weeks for Covishield as against the previous scheme where vaccination bookings could be made six weeks..
IndiaTimes - Published

CoWIN reconfigured: Covishield second dose appointment after 84 days, existing booking to remain valid

CoWIN digital portal has been reconfigured to reflect changes in dose interval of Covishield vaccine to 12-16 weeks, said the Health Ministry.
DNA - Published

Not cancelling existing online bookings for 2nd Covishield dose: Govt

The Union health ministry on Sunday clarified that all those people who had already booked online appointments for the second dose of Covishield vaccine will be able to get the shot.The clarification..
IndiaTimes - Published

Govt on increased gap in Covishield doses : ‘Driven by science’

While the UK has decided to shorten the gap between Covishield doses, the Centre stood by its decision to increase the gap, and said it was based on assessment of experts and no controversy be created..
IndiaTimes - Published

Delhi: People turned away as 12-week rule for Covishield dose kicks in

Two days after the Centre approved extending the gap between two doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks, many people in the 45+ age group who had booked their second dose on the..
IndiaTimes - Published

1 year vaccine dose interval fine but 4 weeks is ideal: Top virologist

The Centre’s advisory to states to extend the interval between the first and second doses of Covishield vaccine to 12-16 weeks from the earlier 6-8 weeks has left many senior citizens confused. Those..
IndiaTimes - Published

'Extended gap between 2 doses of Covishield reasonable approach,' says US advisor Dr Fauci

"The fact that you delay it that long, it is very unlikely that it would have a negative effect on the efficacy of the vaccine," Fauci said.
DNA - Published

Centre increases gap between two doses of Covishield to 12-16 weeks


IndiaTimes - Published

COVID-19: Government panel recommends 12-16 week gap between Covishield doses, no changes for Covaxin

The National Immunization Technical Advisory Group said pregnant women can choose their vaccine and lactating women will also be eligible for vaccine.
DNA - Published

Covid vaccines in India: All FAQs answered

On May 1, the government opened its vaccination drive against Covid -19 for all above 18 years. India has been inoculating people against Covid-19 since January using two Covid vaccines - Covishield..
IndiaTimes - Published

Don’t fret if second dose delayed, no need to restart vaccine schedule, say experts

First-dose recipients of Covaxin don't need to restart their vaccination schedule if the gap between doses goes beyond the recommended 4-6 week interval, a top public health official has said. Experts..
IndiaTimes - Published

Govt rejects SII plea to export 50 lakh doses of Covishield to UK

Despite the international pressure and several rounds of negotiations by Serum Institute of India (SII), the government has turned down the request from SII to export 50 lakh doses of Covishield to UK..
IndiaTimes - Published

Gave some aid for clinical trials of Covaxin and Covishield, not R&D: Centre to SC


IndiaTimes - Published

At Rs 700-Rs 1,500, price of Covid vaccine in India’s private sector among costliest

From Rs 250, the cost of vaccines in the private sector has shot up by up to six times. It now ranges from Rs 700-900 for Covishield manufactured by the Serum Institute of India (SII) and Rs..
IndiaTimes - Published

Karnataka to begin COVID-19 vaccination drive for 18+ from THIS date

It was only on Saturday that Karnataka's stocks were replenished by the arrival of 3.5 lakh Covishield vaccine doses.
DNA - Published

50 lakh Covishield doses meant for export to UK to be used in India for vaccinating 18-plus


IndiaTimes - Published

US supplies of vaccine components to India to enable manufacturing of two crore doses of Covishield

The US on Wednesday said the vaccine components it has supplied to India this week will enable the manufacturing of two crore doses of the Covishield vaccine even as the sixth shipment of American..
IndiaTimes - Published


 Page 1  〉